Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vanguard Mid-Cap Index Fund ETF Shares (VO)

Delayed Data
As of Nov 30
 -0.39 / -0.31%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the performance of a benchmark index that measures the investment return of mid-capitalization stocks. The fund employs an indexing investment approach designed to track the performance of the CRSP US Mid Cap Index, a broadly diversified index of stocks of mid-size U.S. companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

No recent news for Vanguard Mid-Cap Index Fund ETF Shares.


1 month+1.70% 3 years+17.51%
3 months+2.25% 5 years+13.50%
1 year+1.71% Since inception+9.39%
Data through 11/28/2015

Quote Details

Previous close$124.40
Open day’s range123.84 – 124.65
Net asset value (NAV)124.36 (11/27/2015)
Daily volume378,176
Average volume (3 months)399,223
Data as of 3:59pm ET, 11/30/2015

Peer Comparisonvs. Mid-cap blend ETFs

Performance 5-yr return+13.50%+12.76%
Expense Gross exp ratio0.09%0.46%
Risk 5 year sharpe ratio1.050.94
Net assets$66.3B$2.7B
Average market cap$11.0B$6.6B
Average P/E20.418.1
Dividend / Share--0.23%


IWR iShares Russell Mid-Cap ETF
KNOW Direxion All Cap Insider Sentiment Share...
TTFS AdvisorShares TrimTabs Float Shrink ETF


Top 5 Sectors
Portfolio weighting
Financial service 17.05%
Industrial materials 14.95%
Consumer goods 10.54%
Consumer service 9.84%
Energy 9.79%
Top 10 Holdings
Portfolio weighting
AVB AvalonBay Communities0.72%
FISV Fiserv Inc0.71%
EA Electronic Arts Inc0.67%
ROST Ross Stores Inc0.65%
CERN Cerner Corp0.64%
FIS Fidelity National Information Services Inc0.64%
CMG Chipotle0.62%
HIG Hartford Financial Services Group Inc0.60%
INCY Incyte Corp0.60%
BMRN Biomarin Pharmaceutical Inc0.59%